Sunday, September 14, 2025

Trade for 4 days next week alongside this pro trader

A free Open House with Scott Redler ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­  

A free Open House with Scott Redler ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­  

Nature Meets Nasdaq 🀝


Public Health Needs Better Pest Control
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

A Message From Med-x Inc:

Med-X Gearing Up For a Possible NASDAQ Listing (Ticker: MXRX)

But the Real Opportunity is Now – Before They Hit the Big Stage


In certain use cases, their all-natural pesticides have outperformed chemical brands in independent lab tests, providing safer solutions without sacrificing results.


The global biopesticide market is expected to grow ~3X by 2030, from $5.8 billion in 2022 to an impressive $17.6 billion by 20301. Med-X expects pesticide bans and other regulatory actions around the world to fuel their vision of Nature-Cide as the world's leading "clean" pest control product.


Its plant-based formulation not only prioritizes safety, but delivers industrial-grade results, challenging long-held assumptions about what natural products can achieve in professional settings.


NASDAQ Ticker: MXRX Reserved!
The Real Opportunity to Become a Shareholder is Now!


Med-X has earned national and international recognition for providing effective alternatives to conventional pesticides across residential, commercial, and the agricultural sectors. Proudly produced in the USA under strict quality standards, Nature-Cide reflects their commitment to sustainable pest management innovation.


Med-X products are already available through e-commerce giants like Walmart, Amazon, and Kroger, and they plan to expand internationally.


With $6.4M in sales in just four years, expanding to 41 international markets, Med-X is getting ready for the next step...


Simpler, Safer, More Effective Pesticides

Become A Med-X Shareholder At $4 Per Share Before Their NASDAQ Plans Unfold

Disclosures: This is a paid advertisement for Med-X's Regulation A+ Offering.
Please read the offering circular at invest.medx-rx.com

1. Vantage Market Research - www.vantagemarketresearch.com/industry-report/biopesticides-market-1854


This message is a paid advertisement for Med-x Inc. via Investing Media Solutions. Schaeffer's Investment Research Inc. receives a fixed fee for each subscriber that clicks on a link in this email. Other than the compensation received for this advertisement sent to subscribers, Schaeffer's Investment Research Inc. and its principals are not affiliated with Med-x Inc. Schaeffer's Investment Research Inc. and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither Schaeffer's Investment Research Inc. nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from Schaeffer's Investment Research Inc. to buy or sell any security. Schaeffer's Investment Research Inc. has not evaluated the accuracy of any claims made in this advertisement. Schaeffer's Investment Research Inc. recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding Med-x Inc. on the Med-x Inc. website for additional information.



Bitcoin, Dogecoin, XRP Gain; Ethereum Trades Flat: Analyst Predicts ETH Reversal Before...

Leading cryptocurrencies rose in tandem with stocks on Monday, as investors increased their risk appetite ahead of key inflation data reports.
 
TechnicalTrading Logo
Bitcoin, Dogecoin, XRP Gain; Ethereum Trades Flat: Analyst Predicts ETH Reversal Before Q4 Parabolic Rally

Leading cryptocurrencies rose in tandem with stocks on Monday, as investors increased their risk appetite ahead of key inflation data reports. Continue reading ➔
What's Going On With Dell Stock Thursday?

Dell Technologies Inc. (NYSE:DELL) is in the spotlight Thursday ahead of its second quarter earnings report today after the market closes. Continue reading ➔
Stanley Druckenmiller and Nvidia Just Piled Into This Obscure Startup - Ad

Amazon delivers 20 million packages a day... powers some of the most popular websites... delivers medication to half of the U.S. population... and even produces award-winning films and TV shows. But a Wall Street legend - twice featured on 60 Minutes - predicts that "Amazon Helios" will be bigger than all of those... COMBINED. Access its name and ticker symbol here
What's Happening With Regeneron Pharmaceuticals Stock On Monday?

Regeneron's Phase 3 trials for cat and birch allergies show significant symptom relief and strong safety results, paving the way for future development. Continue reading ➔
Epstein accuser Virginia Giuffre wrote a memoir. Months after her death, it's coming out

NEW YORK (AP) — A posthumous and “unsparing” memoir by one of most prominent accusers, will be published this fall, publishing house Alfred A. Knopf said Sunday. Continue reading ➔
Trump Signs Law to Launch Dollar 2.0 - Ad

Trump just signed law S.1582, unleashing the biggest money shift in 100+ years. For the first time since 1913, private firms - not the Fed - can mint a "Dollar 2.0." Treasury says it could drain $6.6T from banks and pay 10X current savings rates. Early investors in minting firms could see 40X returns by 2032. Go here now to make sure you get ahead of it.
A preliminary report on Lisbon's streetcar tragedy is expected Friday

LISBON, Portugal (AP) — Details started to emerge about the people who were killed when a derailed, as the first investigative report examining what caused the popular Lisbon tourist attraction to crash was expected to be released Friday. Continue reading ➔
Mystery surrounds $1.2 billion Army contract to build huge detention tent camp in Texas desert

WASHINGTON (AP) — When last month awarded a contract worth up to $1.2 billion to build and operate what it says will become , it didn’t turn to a large government contractor or even a firm that specializes in private prisons. Continue reading ➔
The New Way to Use AI in the Stock Market... - Ad

A Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took dozens of technology and finance experts, including one PhD astrophysicist, and $4 million in total research costs). In a multi-year backtest, this breakthrough beat stocks, bonds, gold... even Warren Buffett. Try it out for yourself here.
Macron Warns World Will Know By Monday If Putin 'Played' Trump Again

French President Emmanuel Macron has voiced apprehensions about Vladimir Putin potentially manipulating President Trump. Continue reading ➔
Mortgage Fraud Is Now A Trump-Era Flashpoint—Here's Everything You Need To Know

Given the recent high-profile cases, Benzinga decided to take a closer look at what mortgage fraud is and how it can be committed. Continue reading ➔
October 16 Changes the Microchip Game - and Investing - Ad

George Gilder-dubbed "America's #1 Futurist"-says while everyone's chasing AI, the real opportunity is in a 4-nanometer tech millions of times more complex. It's not another chip - it replaces them. Now built in Arizona, Gilder says 3 companies tied to this "super-convergence" could soar. Get his complete research here.
Trump To Seal US-UK Tech Pact On AI, Chips And Quantum Computing During London Visit: Report

The U.S. and UK are set to sign a major tech agreement focusing on AI, semiconductors, and quantum computing. Continue reading ➔
Heads Up! The Bear Cave Nails These Pump-And-Dump Stocks: QMMM, Cuprina, Pitanium, Mint And More

The Bear Cave warns about a rash of pump-and-dump stock schemes revolving around thinly traded China-based stocks. Continue reading ➔
Qualcomm And Valeo Broaden Collaboration To Speed Hands Off Driving Features

Qualcomm and Valeo partner to launch ADAS and AD solutions, integrating Snapdragon Ride SoC and software stack with Valeo's sensors and systems. Continue reading ➔
Carney Cuts The Red Tape, Unveils Over $43 Billion In Flagship Projects

PM Mark Carney announces first projects to be reviewed by Canada's new Major Projects Office, aiming to cut red tape and attract investments. Continue reading ➔
Charlie Munger's Financial Success Advice: 'My Game in Life Was Always To Avoid All Standard Ways of Failing, Because I'm So Cautious'

The late billionaire Charlie Munger once shared his unique approach to financial success and longevity. Continue reading ➔
How Malawi is taking AI technology to small-scale farmers who don't have smartphones

MULANJE, Malawi (AP) — Alex Maere survived the destruction of when it tore through southern Malawi in 2023. His farm didn't. Continue reading ➔

Page List

Blog Archive

Search This Blog

Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company

A free briefing uncovers the 4-letter ticker behind this pre-IPO story ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏...